Synthesis and phospholipase C inhibitory activity of D609 diastereomers

被引:36
作者
González-Roura, A [1 ]
Casas, J [1 ]
Llebaria, A [1 ]
机构
[1] CSIC, IIQAB, Dept Biol Organ Chem, RUBAM, ES-08034 Barcelona, Spain
关键词
D O I
10.1007/s1145-002-0908-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The potassium xanthate D609 is widely accepted as a selective inhibitor of PC-specific phospholipase C (PC-PLC). The tricyclo[5.2.1.0(2.6)]decane skeleton present in D609 can lead to four diastereomeric pairs, but the diastereoselectivity of PC-PLC inhibition has never been reported. In this article, the synthesis of racemic D609 diastereomers and that of other xanthates, as well as their inhibitory effect on PC-PLC is reported. All xanthates obtained were competitive inhibitors of PC-PLC from Bacillus cereus (PLCBc). No significant differences were found in the activity of D609 diastereomers (K-i 13-17 muM), suggesting the absence of a diastereochemical control of the enzyme by xanthate inhibitors. This result was confirmed after obtaining other potassium xanthates differing from D609 in the aliphatic chain. Among them, the potassium O-n-decenylxanthate was the most active inhibitor of PLCBc (K-i 10 muM). These data indicate that the essential structural requirements for PLCBc in vitro inhibition by xanthates are the presence of a Zn-chelating dithiocarbonate head and a sufficiently hydrophobic aliphatic moiety.
引用
收藏
页码:401 / 406
页数:6
相关论文
共 50 条
[21]   Protection by D609 Through Cell-Cycle Regulation After Stroke [J].
Adibhatla, Rao Muralikrishna ;
Hatcher, James F. .
MOLECULAR NEUROBIOLOGY, 2010, 41 (2-3) :206-217
[22]   Effect of D609 on IP3 and DAG levels in cultured hepatocytes. [J].
Sandnes, D ;
Dajani, O ;
Christoffersen, T .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) :R674-R674
[23]   What Is the True Structure of D609, a Widely Used Lipid Related Enzyme Inhibitor? [J].
Kato, Mikako ;
Hammam, Mostafa A. S. ;
Taniguchi, Tohru ;
Suga, Yoshiko ;
Monde, Kenji .
ORGANIC LETTERS, 2016, 18 (04) :768-771
[24]   D609 inhibits ionizing radiation-induced oxidative damage by acting as a potent antioxidant [J].
Zhou, DH ;
Lauderback, CM ;
Yu, T ;
Brown, SA ;
Butterfield, DA ;
Thompson, JS .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 298 (01) :103-109
[25]   Phosphatidylcholine-specific phospholipase inhibitor D609 differentially affects MAP kinases and immediate-early genes in PC12 cells [J].
Kahle, PJ ;
Shooter, EM ;
Johnson, RM ;
Verity, AN .
CELLULAR SIGNALLING, 1998, 10 (05) :321-330
[26]   D609 Inhibits Progression of Preexisting Atheroma and Promotes Lesion Stability in Apolipoprotein E-/- Mice A Role of Phosphatidylcholine-Specific Phospholipase in Atherosclerosis [J].
Zhang, Lu ;
Zhao, Jing ;
Su, Le ;
Huang, Bin ;
Wang, Li ;
Su, Hua ;
Zhang, Yun ;
Zhang, ShangLi ;
Miao, JunYing .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (03) :411-U90
[27]   Priming of alveolar macrophage respiratory burst by H2O2 is prevented by phosphatidylcholine-specific phospholipase C inhibitor tricyclodecan-9-yl-xanthate (D609) [J].
Girón-Calle, J ;
Srivatsa, K ;
Forman, HJ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (01) :87-94
[28]   ANTIVIRAL EFFECTS OF XANTHATE D609 ON THE HUMAN RESPIRATORY SYNCYTIAL VIRUS GROWTH-CYCLE [J].
VILLANUEVA, N ;
NAVARRO, J ;
CUBERO, E .
VIROLOGY, 1991, 181 (01) :101-108
[29]   Two distinct Fas-activated signaling pathways revealed by an antitumor drug D609 [J].
Lilin Zhang ;
Shigeomi Shimizu ;
Yoshihide Tsujimoto .
Oncogene, 2005, 24 :2954-2962
[30]   Synthesis and evaluation of fluorogenic substrates for phospholipase D and phospholipase C [J].
Rose, Tyler M. ;
Prestwich, Glenn D. .
ORGANIC LETTERS, 2006, 8 (12) :2575-2578